Barclays
RGLS

Barclays’s Regulus Therapeutics RGLS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-64,636
Closed -$113K 4531
2025
Q1
$113K Sell
64,636
-31,611
-33% -$55.3K ﹤0.01% 3644
2024
Q4
$152K Buy
96,247
+11,770
+14% +$18.6K ﹤0.01% 3633
2024
Q3
$132K Buy
84,477
+62,549
+285% +$97.7K ﹤0.01% 3668
2024
Q2
$40K Buy
+21,928
New +$40K ﹤0.01% 3761
2023
Q3
Sell
-225
Closed 4359
2023
Q2
$0 Buy
225
+220
+4,400% ﹤0.01% 4383
2023
Q1
$0 Buy
+5
New ﹤0.01% 4391
2021
Q4
Sell
-50
Closed 3725
2021
Q3
$0 Buy
+50
New ﹤0.01% 4106
2019
Q2
Sell
-7
Closed 4385
2019
Q1
$0 Hold
7
﹤0.01% 4383
2018
Q4
$0 Sell
7
-7,982
-100% ﹤0.01% 4328
2018
Q3
$2K Buy
7,989
+7,900
+8,876% +$1.98K ﹤0.01% 4185
2018
Q2
$0 Sell
89
-2
-2% ﹤0.01% 4342
2018
Q1
$0 Buy
91
+2
+2% ﹤0.01% 4342
2017
Q4
$0 Hold
89
﹤0.01% 4164
2017
Q3
$0 Sell
89
-49,600
-100% ﹤0.01% 4107
2017
Q2
$49K Buy
49,689
+6,582
+15% +$6.49K ﹤0.01% 3030
2017
Q1
$71K Sell
43,107
-3,252
-7% -$5.36K ﹤0.01% 2978
2016
Q4
$103K Buy
46,359
+39,275
+554% +$87.3K ﹤0.01% 2585
2016
Q3
$23K Sell
7,084
-326
-4% -$1.06K ﹤0.01% 2989
2016
Q2
$22K Buy
7,410
+700
+10% +$2.08K ﹤0.01% 2790
2016
Q1
$40K Sell
6,710
-462
-6% -$2.75K ﹤0.01% 2613
2015
Q4
$58K Sell
7,172
-15,027
-68% -$122K ﹤0.01% 2443
2015
Q3
$133K Buy
22,199
+10,725
+93% +$64.3K ﹤0.01% 2279
2015
Q2
$115K Buy
11,474
+10,448
+1,018% +$105K ﹤0.01% 2304
2015
Q1
$16K Sell
1,026
-2,150
-68% -$33.5K ﹤0.01% 3195
2014
Q4
$51K Sell
3,176
-2,474
-44% -$39.7K ﹤0.01% 3005
2014
Q3
$34K Sell
5,650
-4,815
-46% -$29K ﹤0.01% 3176
2014
Q2
$83K Buy
10,465
+2,382
+29% +$18.9K ﹤0.01% 2814
2014
Q1
$73K Buy
8,083
+7,857
+3,477% +$71K ﹤0.01% 2948
2013
Q4
$1K Sell
226
-156
-41% -$690 ﹤0.01% 4262
2013
Q3
$3K Sell
382
-6,253
-94% -$49.1K ﹤0.01% 3902
2013
Q2
$65K Buy
+6,635
New +$65K ﹤0.01% 3235